ProCE Banner Activity

CROI 2021: My Picks for Interesting HIV Treatment Data From Spain and Beyond

Conference Coverage
Clinical Thought
My picks for interesting HIV treatment data presented at CROI 2021 include 2 studies performed in Spain, one comparing the efficacy of fixed-dose boosted PI combination ART vs second-generation integrase inhibitors and one investigating treatment options for newly diagnosed patients with advanced HIV.

Released: April 01, 2021

Expiration: March 31, 2022

Share

Faculty

José R. Arribas

José R. Arribas, MD

Professor of Medicine
Department of Medicine
Autónoma University School of Medicine
Head, Infectious Diseases Unit
Department of Internal Medicine
Hospital La Paz
Madrid, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Faculty Disclosure

Primary Author

José R. Arribas, MD

Professor of Medicine
Department of Medicine
Autónoma University School of Medicine
Head, Infectious Diseases Unit
Department of Internal Medicine
Hospital La Paz
Madrid, Spain

José R. Arribas, MD, has disclosed that he has received funds for research support from Gilead Sciences, Merck, and ViiV Healthcare and consulting fees from Aelix, Gilead Sciences, Janssen, Merck, Teva, and ViiV Healthcare.